论文部分内容阅读
目的:探讨利胆清胰汤联合内镜逆行胰胆管造影术(ERCP)治疗肝胆湿热证胆源性胰腺炎的临床价值。方法:根据治疗方式不同,将本院2014年3月~2016年4月选择的肝胆湿热证胆源性胰腺炎136例患者,联合组68例,采取ERCP和利胆清胰汤治疗;对照组68例,采取ERCP治疗。治疗两周后,对比联合组和对照组的中医证候积分、APACHE-II评分、尿淀粉酶、血淀粉酶。结果:在两个疗程后,对照组患者中医证候积分总分是494分,明显高出联合组中医证候积分总分360分;对照组的APACHE-II评分(25.73±1.3)显著大于联合组(16.61±1.45);联合组的高淀粉酶血症率10.29%较对照组20.59%更低(P<0.05),差异均有统计学意义。结论:肝胆湿热证胆源性胰腺炎,在ERCP的治疗上连用利胆清胰汤,可改善肝胆湿热证、通气止痛,促进患者早日康复。
Objective: To investigate the clinical value of “Lidan Qingyitang” combined with endoscopic retrograde cholangiopancreatography (ERCP) in the treatment of gallstone pancreatitis caused by hepatobiliary fever. Methods: According to the different treatment methods, 136 patients with hepatobiliary-gallstone fever biliary pancreatitis selected from March 2014 to April 2016 in our hospital were treated with ERCP and Lidan Qingyitang. The control group 68 cases, to take ERCP treatment. After two weeks of treatment, TCM syndrome score, APACHE-II score, urine amylase and blood amylase were compared between the combined group and the control group. Results: After two courses of treatment, the TCM syndrome score of the control group was 494 points, significantly higher than that of the TCM syndrome score of the combination group. The APACHE-II score of the control group (25.73 ± 1.3) was significantly higher than that of the combination group Group (16.61 ± 1.45). The rate of hypermylase in the combined group was 10.29% lower than that in the control group (20.59%, P <0.05). The difference was statistically significant. Conclusion: Hepatobiliary damp-heat syndrome of biliary pancreatitis, the use of ERCP in the treatment of combined with bile Qingyitang can improve the liver and gallbladder damp-heat syndrome, ventilation and pain relief, and promote early recovery of patients.